InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（13 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
13
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the complete record of transactions filed by Chess Robert, Lead Independent Director. Insider active across 3 companies, notably NEKTAR THERAPEUTICS. Aggregated, 27 disclosures have been published. Breakdown: 0 buy · 13 sells. Total volume traded: €2.2m. Activity tracked since 12 May 2021. The latest transaction was disclosed on 17 March 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Chess Robert
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报27 总计
10,000 股@ US$11.894.6% 占其流量Common StockSEC:0001214659-26-003483:0
2,184 股@ US$48.2613.8% 占其流量Common StockSEC:0001214659-26-002125:0
5,095 股0Common StockSEC:0001214659-26-001342:0
2,940 股@ US$53.1353.9% 占其流量Common StockSEC:0001214659-25-002410:0
4,472 股0Common StockSEC:0001214659-25-002229:0
5,000 股@ US$50.006.2% 占其流量Common StockSEC:0001214659-25-000445:0
3,504 股@ US$8.820.8% 占其流量Common StockSEC:0001214659-24-021151:0
3,600 股@ US$8.820.8% 占其流量Common StockSEC:0000950170-24-126641:0
19,500 股@ US$1.205.8% 占其流量Common StockSEC:0000950170-24-073851:0
5,815 股0Common StockSEC:0001214659-24-002250:0
10,200 股@ US$0.672.0% 占其流量Common StockSEC:0001209191-23-050222:0
8,212 股0Common StockSEC:0001214659-23-001879:0
5,100 股@ US$3.194.4% 占其流量Common StockSEC:0001209191-22-051303:0
10,200 股0Common StockSEC:0001209191-22-050812:0
3,491 股0Common StockSEC:0001214659-22-002208:0
253 股@ US$58.8790.6% 占其流量Common StockSEC:0001214659-22-002067:0
4,000 股@ US$120.153417.6% 占其流量Common StockSEC:0001214659-21-011105:0
3,700 股@ US$120.14616.2% 占其流量Common StockSEC:0001214659-21-010741:0
300 股@ US$120.001.3% 占其流量Common StockSEC:0001214659-21-010680:0
10,200 股0Common StockSEC:0001209191-21-057703:0
4,000 股@ US$120.227117.2% 占其流量Common StockSEC:0001214659-21-009507:0
8,000 股@ US$13.8036.7% 占其流量Common StockSEC:0001209191-21-055543:0
6,300 股0Common StockSEC:0001209191-21-053541:0
2,106 股@ US$13.809.7% 占其流量Common StockSEC:0001209191-21-047868:0
610 股@ US$124.36952.7% 占其流量Common StockSEC:0001214659-21-007500:0
27 条申报中的 25 条
About Chess Robert
CHESS ROBERT is Lead Independent Director and a director at Twist Bioscience Corp and NEKTAR THERAPEUTICS. He has made 27 filings, and the 27 sampled filings show sales totaling EUR 2240606 between 2021-05-14 and 2026-03-19.
